Company · CIK 0001593899
Atea Pharmaceuticals, Inc.
AVIRSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$5.14−$0.02 (−0.291%)
AVIR · Last trade
- Prev close
- $5.16
- Range (30d)
- $5.01 – $5.64
On the record
Recent filings
- SCHEDULE 13GAVIRAtea Pharmaceuticals, Inc.0001214659-26-012604 · 27.3 KBSEC(opens sec.gov)
- 10-QAVIRQuarterly update0001193125-26-347021 · 9.2 MBSEC(opens sec.gov)
- 8-KAVIRCurrent report0001193125-26-346888 · 226.1 KBSEC(opens sec.gov)
- 8-KAVIRCurrent report0001193125-26-277639 · 147.8 KBSEC(opens sec.gov)
- 10-QAVIRQuarterly update0001193125-26-219678 · 8.1 MBSEC(opens sec.gov)
- 8-KAVIRCurrent report0001193125-26-219507 · 208.5 KBSEC(opens sec.gov)
- 10-KAVIRAnnual report0001193125-26-094159 · 16.6 MBSEC(opens sec.gov)
- 8-KAVIRCurrent report0001193125-26-093961 · 224.6 KBSEC(opens sec.gov)
- 8-KAVIRCurrent report0001193125-26-007081 · 183.4 KBSEC(opens sec.gov)
- 10-QAVIRQuarterly update0001193125-25-277815 · 9.4 MBSEC(opens sec.gov)
Insiders
- Adams Jerome M.Director
- BERGER FRANKLIN MDirector
- Berman HowardDirector
- Chen BihuaDirector, 10% Owner
- Cheng IsaacDirector
- Chu Chung K.10% Owner
- Corcoran AndreaSee Remarks
- Cormorant Asset Management, LPFormer 10% Owner
- Cormorant Private Healthcare Fund II, LP10% Owner
- CORMORANT PRIVATE HEALTHCARE FUND I, LP10% Owner
Tickers
Addresses
business
225 FRANKLIN STREET SUITE 2100
BOSTON, MA, 02110
mailing
225 FRANKLIN STREET SUITE 2100
BOSTON, MA, 02110
Same industry